Form 8-K - Current report:
SEC Accession No. 0001493152-24-014646
Filing Date
2024-04-15
Accepted
2024-04-15 17:00:17
Documents
13
Period of Report
2024-04-10
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 108128
  Complete submission text file 0001493152-24-014646.txt   285364

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE orgs-20240410.xsd EX-101.SCH 3018
3 XBRL LABEL FILE orgs-20240410_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE orgs-20240410_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3493
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 24845307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)